XWX-30472-66015
4 vaccinations
5 coded responses
47 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 405 / KY
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Registered in v-safe
-
2021-01-23
Dose 1 — Pfizer-BioNTech
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-29
- 2021-01-30
- 2021-02-06
- 2021-02-13
-
2021-02-19
Dose 2 — Pfizer-BioNTech
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-05-21
- 2021-08-20
-
2021-09-21
Dose 3 — Pfizer-BioNTech
- 2021-10-01
- 2021-10-05
- 2021-10-12
-
2021-10-19
Survey response — 28 day, dose 3MedDRA: Pre-existing disease — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
- 2021-10-26
- 2021-11-02
-
2021-12-22
Survey response — 3 month, dose 3MedDRA: Corneal erosion, Keratectomy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2022-03-22
Survey response — 6 month, dose 3MedDRA: Macular hole, Office visit, Tinnitus — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11 · check-in answers available
-
2022-03-22
Report sent to call center — 6 month, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-03-23
-
2022-03-25
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-05-14
Dose 4 — Pfizer-BioNTech
- 2022-05-14
- 2022-05-15
- 2022-05-16
- 2022-05-17
- 2022-05-18
- 2022-05-19
- 2022-05-20
- 2022-05-21
- 2022-05-28
- 2022-06-04
- 2022-06-11
- 2022-06-18
-
2022-06-25
Survey response — 42 day, dose 4MedDRA: Corneal erosion, Macular hole — Feeling: FairMedDRA releases: 2024-11 · check-in answers available
-
2022-08-13
Survey response — 3 month, dose 4MedDRA: Cough, Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2022-11-12
- 2023-05-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | |
| 3 | 2021-09-21 | Pfizer-BioNTech | No |
| 4 | 2022-05-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-22 | Successful 2022-03-25 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 10
Symptoms: Seasonal allergies
Symptoms: Cornea erosion-Minor issues began in Apr '21-long term sub for School Yr 2020-21, masking daily for school and any other outing. Issues elevated in Oct and had keratectomy 11/1/21. Required PKT laser 12/17/21. My masks allowed too much air in eyes. cut off by CDC
Release 11
Symptoms: Macular hole Tinnitus
Healthcare visit (other): Retina Specialist AND ENT
Release 12
Symptoms: Once again having trouble with cornea erosion in one eye. The other eye is still revive from a macular hole late March.
Symptoms: Summer Cold & Cough
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Corneal erosion | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Keratectomy | · | · | ✓ |
| SD | Macular hole | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Tinnitus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release